Effect of Insulin Resistance on the Safety and Efficacy of Pegylated Interferon and Ribavirin Treatment in HCV (Study P05562)

NCT00705224 · clinicaltrials.gov ↗

COMPLETED

Status

250

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis C, Chronic
Hepatitis C Virus

Interventions

BIOLOGICAL: Pegylated Interferon
DRUG: Ribavirin

Sponsor

Merck Sharp & Dohme LLC